Human Lactation 3 pp 213-225 | Cite as
β-casomorphins: Do They Have Physiological Significance?
Chapter
Abstract
Milk represents an essential food for the newborn mammal. In addition to nutrients milk contains a variety of important materials, e.g. substances with immunological relevance1 and a considerable number of hormones whose physiological significance is not yet clearly understood.2
Keywords
Opioid Peptide Bovine Milk Milk Intake Nursing Female Opioid Activity
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.L.A. Hanson, The mammary gland as an immunological organ, Immunol. Today 3: 168 (1982).CrossRefGoogle Scholar
- 2.O. Koldovsky, Hormones in milk, Life Sei. 26: 1833 (1980).CrossRefGoogle Scholar
- 3.V. Brantl and H. Teschemacher, Opioids in milk, Trends Pharmacol. Sei 4: 193 (1983).Google Scholar
- 4.V. Brantl and K. Neubert, Opioid peptides derived from food proteins, Trends Pharmacol. Sci. 7: 6 (1986).CrossRefGoogle Scholar
- 5.C. Zioudrou and W.A. Klee, Possible roles of peptides derived from food proteins in brain functions, in: “Nutrition and the Brain”, R.J. Wurtman and J.J. Wurtman, eds., Raven Press, New York (1979).Google Scholar
- 6.S. Loukas, D. Varoucha, C. Zioudrou, R.A. Streaty and W.A. Klee, Opioid activities and structures of α-caseinderived exorphins, Biochemistry 22:4567 (1983).CrossRefGoogle Scholar
- 7.V. Brantl, H. Teschemacher, A. Henschen and F. Lottspeich, Novel opioid peptides derived from casein (ß-casomorphins): I. Isolation from bovine casein peptone, Hoppe-Seyler’s Z. Physiol. Chem. 360:1211 (1979).CrossRefGoogle Scholar
- 8.V. Brantl, Novel opioid peptides derived from human ß-casein: human ß-casomorphins, Eur. J. Pharmacol. 106:213 (1984).CrossRefGoogle Scholar
- 9.I.S. Zagon, P.J. McLaughlin, D.J. Weaver and E. Zagon, Opiates, endorphins and the developing organism: A comprehensive bibliography, Neurosci. Biobehav. Rev. 6:439 (1982).CrossRefGoogle Scholar
- 10.B. Ribadeau-Dumas, G. Brignon, F. Grosclaude and J.-C. Mercier, Structure primaire de la caseine ß-bovine: Sequence complete, Eur. J. Biochem. 25:505 (1972).CrossRefGoogle Scholar
- 11.A. Henschen, F. Lottspeich, V. Brantl and H. Teschemacher, Novel opioid peptides derived from casein (ß-casomorphins). II. Structure of active components from bovine casein peptone, Hoppe-Seyler’s Z. Physiol. Chem. 360:1216 (1979).Google Scholar
- 12.F. Lottspeich, A. Henschen, V. Brantl and H. Teschemacher, Novel opioid peptides derived from casein (ß-casomorphins). III. Synthetic peptides corresponding to components from bovine casein peptone, Hoppe-Seyler’s Z. Physiol. Chem. 361:1835 (1980).CrossRefGoogle Scholar
- 13.V. Brantl, H. Teschemacher, J. Bläsig, A. Henschen and F. Lottspeich, Opioid activities of ß-casomorphins, Life Sci. 28:1903 (1981).CrossRefGoogle Scholar
- 14.K.-J. Chang, P. Cuatrecasas, E.T. Wei and J.-K. Chang, Analgesic activity of intracerebroventicular administration of morphiceptin and ß-casomorphins: Correlation with the morphine (μ) receptor binding affinity, Life Sci, 30:1547 (1982).CrossRefGoogle Scholar
- 15.B.C. Richardson and J.C. Mercier, The primary structure of the ovine ß-caseins, Eur. J. Biochem. 99:285 (1979).CrossRefGoogle Scholar
- 16.P. Petrilli, F. Addeo and L. Chianese, Primary structure of water buffalo ß-casein: Tryptic and CNBr peptides, Ital. J. Biochem. 32:336 (1983).Google Scholar
- 17.R. Greenberg, M.L. Groves and H.J. Dower, Human ß-casein. Amino acid sequence and identification of phosphorylation sites, J. Biol. Chem. 259:5132 (1984).Google Scholar
- 18.G. Koch, K. Wiedemann and H. Teschemacher, Opioid activities of human ß-casomorphins, Naunyn-Schmiedeberg’s Arch. Pharmacol. 331:351 (1985).CrossRefGoogle Scholar
- 19.M. Yoshikawa, T. Yoshimura and H. Chiba, Opioid peptides from human ß-casein, Agric. Biol. Chem. 48:3185 (1984).CrossRefGoogle Scholar
- 20.W. Kromer, W. Pretzlaff and R. Woinoff, Regional Distribution of an opioid mechanism in the guinea-pig isolated intestine, J. Pharm. Pharmacol. 33:98 (1981).CrossRefGoogle Scholar
- 21.G. Grecksch, C. Schweigert and H. Matthies, Evidence for analgesic activity of ß-casomorphin in rats, Neurosci. Lett. 27:325 (1981).CrossRefGoogle Scholar
- 22.K.G. Reymann, A.N. Chepkova, K. Schulzeck and T. Ott, Effects of ß-casomorphin on dentate hippocampal field potentials in freely moving rats, Biomed. Biochim. Acta 44:749 (1985).Google Scholar
- 23.V. Schusdziarra, A. Holland, R. Schick, A. de la Fuente, M. Klier, V. Maier, V. Brantl and E.F. Pfeiffer, Modulation of post-prandial insulin release by ingested opiate-like substances in dogs, Diabetologia 24:113 (1983).CrossRefGoogle Scholar
- 24.V. Schusdziarra, R. Schick, A. de la Fuente, A. Holland, V. Brantl and E.F. Pfeiffer, Effect of ß-casomorphins on somatostatin release in dogs, Endocrinologyy 112:1948 (1983).CrossRefGoogle Scholar
- 25.V. Schusdziarra, R. Schick, A. Holland, A. de la Fuente, J. Specht, V. Maier, V. Brantl and E.F. Pfeiffer, Effect of opiate-active substances on pancreatic polypeptide levels in dogs, Peptides 4:205 (1983).CrossRefGoogle Scholar
- 26.T. Mitsuma, T. Nogimori and M. Chaya, ß-Casomorphin inhibits thyrotropin secretion in rats, Exp. Clin. Endocrinol. 84:324 (1984).CrossRefGoogle Scholar
- 27.J. Nedvidkova, E. Kasafirek, A. Dlabac and V. Felt, Effect of beta-casomorphin and its analogue on serum prolactin in the rat, Exp. Clin. Endocrinol. 85:249 (1985).CrossRefGoogle Scholar
- 28.J.E. Zadina and A.J. Kastin, Interactions between the antiopiate Tyr-MIF-1 and the Mu opiate morphiceptin at their respective binding sites in brain, Peptides 6:965 (1985).CrossRefGoogle Scholar
- 29.F. Parker, D. Migliore-Samour, F. Floch, A. Zerial, G.H. Werner, J. Jolies, M. Casaretto, H. Zahn and P. Jolies, Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties, Eur. J. Biochem. 145:677 (1984).CrossRefGoogle Scholar
- 30.P. Petrilli, D. Picone, C. Caporale, F. Addeo, S. Auricchio and G. Marino, Does casomorphin have a functional role? FEBS Lett. 169:53 (1984).CrossRefGoogle Scholar
- 31.J. Svedberg, J. de Haas, G. Leimenstoll, F. Paul and H. Teschemacher, Demonstration of ß-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans, Peptides 6:825 (1985).CrossRefGoogle Scholar
- 32.K.-J. Chang, Y.F. Su, D.A. Brent and J.-K. Chang, Isolation of a specific u-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteins, J. Biol. Chem. 260:9706 (1985).Google Scholar
- 33.B. Hartrodt, K. Neubert, G. Fischer, U. Demuth, T. Yoshimoto and A. Barth, Degradation of ß-casomorphin-5 by proline-specific endopeptidase (PSE) and post-proline cleaving enzyme (PPCE), Pharmazie 37:72 (1982).Google Scholar
- 34.B. Hartrodt, K. Neubert, G. Fischer, H. Schulz and A. Barth, Synthese und enzymatischer Abbau von ß-Casomorphin-5, Pharmazie 37:165 (1982).Google Scholar
- 35.G. Kreil, M. Umbach, V. Brantl and H. Teschemacher, Studies on the enzymatic degradation of ß-casomorphins, Life Sci. 33, Suppl. 1:137 (1983).CrossRefGoogle Scholar
- 36.M. Umbach, H. Teschemacher, K. Praetorius, R. Hirschhäuser and H, Bostedt, Demonstration of a ß-casomorphin immurioreactive material in the plasma of newborn calves after milk intake, Reg. Peptides 12:223 (1985).CrossRefGoogle Scholar
- 37.G. Koch, K. Wiedemann and W. Zimmermann, Human β-Casomorphin-8 Immunoreactive materials in the plasma of nursing mothers, Naunyn-Schmiedeberg’s Arch. Pharmacol. 332:R 85 (1986).Google Scholar
- 38.H. Stark, B. Lössner and H. Matthies, Degradation of ß-casomorphin in the rat brain in vivo, Biomed. Biochim. Acta 45:557 (1986).Google Scholar
- 39.H. Meisel, Chemical characterization and opioid activity of an exorphin isolated from in vivo digests of casein, FEBS Lett. 196:223 (1986).CrossRefGoogle Scholar
- 40.J.E. Morley, Food peptides: A new class of hormones? J. Am. Med. Assoc. 247:2379 (1982).CrossRefGoogle Scholar
- 41.H. Teschemacher, M. Umbach, U. Hamel, K. Praetorius, G. Ahnert-Hilger, V. Brantl, F. Lottspeich and A. Henschen, No evidence for the presence of ß-casomor-phins in human plasma after ingestion of cows’ milk or milk products, J. Dairy Res. 53:135 (1986).CrossRefGoogle Scholar
- 42.J. Panksepp, L. Normanseil, S. Siviy, J. Rossi III and A.J. Zolovick, Casomorphins reduce separation distress in chicks, Peptides 5:829 (1984).CrossRefGoogle Scholar
- 43.A. Ermisch, H.-J. Rühle, K. Neubert, B. Hartrodt and R. Landgraf, On the blood-brain barrier to peptides: H ß-casomorphin-5 uptake by eighteen brain regions in vivo, J. Neurochem. 41:1229 (1983).CrossRefGoogle Scholar
- 44.G. Püschel, R. Mentlein and E. Heymann, Isolation and characterization of dipeptidyl peptidase IV from human placenta, Eur. J. Biochem. 126:359 (1982).CrossRefGoogle Scholar
- 45.S.S.C. Yen, M.E. Quigley, R.L. Reid, J.F. Ropert and N.S. Cetel, Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretion, Am. J. Obstet. Gynecol. 152:485 (1985).Google Scholar
- 46.C.A. Leadem and S.P. Kalra, Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats, Neuroendocrinology 41:342 (1985).CrossRefGoogle Scholar
- 47.D.M. Wright, Evidence for a spinal site at which opioids may act to inhibit the milk-ejection reflex, J. Endocrinol. 106:401 (1985).CrossRefGoogle Scholar
- 48.L.H. Lindström, F. Nyberg, L. Terenius, K. Bauer, G. Besev, L.M. Gunne, S. Lyrenäs, G. Willdeck-Lund and B. Lindberg, CSF and plasma ß-casomorphin-like opioid peptides in post-partum psychosis, Am. J. Psychiatry 141:1059 (1984).Google Scholar
Copyright information
© Springer Science+Business Media New York 1987